# Delegations of Authority and Organization; Redelegation to Officials Within the Center for Biologics Evaluation and Research
> **Food and Drug Administration** · Final rule. · Published 1999-09-01 · Effective 1999-09-01 · 64 FR 47669
## Document
- **Document number:** 99-22676
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 64 FR 47669
- **CFR reference:** 21 CFR 5
- **Publication date:** 1999-09-01
- **Effective date:** 1999-09-01
## Abstract

The Food and Drug Administration (FDA) is amending the statements of redelegations of authority to reflect a new redelegation that enables the Director and Deputy Directors of the Center for Biologics Evaluation and Research (CBER) to issue license suspension notifications under the authority given to the Commissioner of Food and Drugs (the Commissioner). This amendment is intended to reflect those redelegations.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1999/09/01/99-22676/delegations-of-authority-and-organization-redelegation-to-officials-within-the-center-for-biologics)
---
*AI Analytics · CC0 1.0*